Press Room

Find news and updates from PhRMA, representing the country’s leading biopharmaceutical research companies. Our members are committed to finding tomorrow’s cures and treatments for some of the most serious diseases such as cancer, Alzheimer’s disease, cystic fibrosis and Parkinson’s.

Latest News from PhRMA

New Reports Highlight Increasing Global Competition in Biopharmaceutical R&D, Posing Significant Challenges to Future U.S. Standing

June 5, 2017

As the U.S. looks to maintain its global leadership in biopharmaceutical research and development, three new reports point to an increasingly competitive global environment.

Read More

Nuevos Informes Destacan el Aumento de la Competencia Global en I + D Biofarmacéutica, Planteando Desafíos Significativos para la Futura Posición de Estados Unidos

June 5, 2017

Mientras los Estados Unidos buscan mantener su liderazgo mundial en la investigación y el desarrollo biofarmacéutico, tres nuevos informes apuntan a un entorno global cada vez más competitivo.

Read More

PhRMA CEO in Forbes - How to negotiate better deals for prescription medicines

June 2, 2017

We're looking for better answers to negotiate better deals for prescription medicines.

Read More

A critical opportunity to prevent prescription drug abuse

June 2, 2017

The FDA's commitment to addressing prescription drug abuse provides a new opportunity for health care stakeholders to work together.

Read More

Celebrating PRIDE in biopharmaceutical science

June 1, 2017

We recognize inclusion and diversity fuels collaboration and trust to make the next leap into biomedical research.

Read More

More than 240 immuno-oncology treatments in development to fight cancer

June 1, 2017

A new report shows there are more than 240 immuno-oncology medicines and vaccines in development to treat cancer.

Read More

New Report Shows More than 240 Immuno-Oncology Treatments in Development for Patients with Cancer

June 1, 2017

A new report released today by the Pharmaceutical Research and Manufacturers of America (PhRMA) in partnership with The American Cancer Society Cancer Action Network (ACS CAN) finds there are more than 240 immuno-oncology medicines and vaccines currently in development.

Read More

ICYMI: Avalere and FasterCures develop new value framework from patient perspective

May 31, 2017

A year-long collaboration between Avalere and FasterCures has resulted in the first value framework from the patient perspective.

Read More

Fighting multiple sclerosis: New Together ad illuminates the journey of patient & scientist

May 31, 2017

This blog post highlights the launch of a new GOBOLDLY advertisement in the Together ad series on multiple sclerosis.

Read More

Medicare Monday: Catch up on MedPAC and its Part B recommendations

May 29, 2017

Reading list on the Medicare Payment Advisory Commission.

Read More